FDA Import Refusal 1FX-6548305-8/10002/1A — Daewoong Lilly Pharm Co Ltd
The FDA refused shipment 1FX-6548305-8/10002/1A from Daewoong Lilly Pharm Co Ltd (South Korea) on May 20, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charges: 3500,472
Refusal Details
- Date
- May 20, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 58PDY05 ONABOTULINUMTOXINA
- Charges
- 3500,472